The FDA adverse-event record for guinea pig

Guinea Pig Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 75 adverse event reports for Guinea Pig, distributed across 0 distinct breeds currently tracked in the system. Of those reports, 37 involved a death outcome, producing a 49.3% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Guinea Pig are Death (33 reports), Anorexia (11 reports), Lack of efficacy - NOS (9 reports), Depression (7 reports), with Death leading the reaction traffic at 33 submissions. On the product side, Selamectin is the single most-referenced drug with 17 reports, followed by Isoflurane (11), Meloxicam (10), Enrofloxacin (9). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Guinea Pig reporting patterns against other companion animals in the dataset.

Of the 63 Guinea Pig reports with a coded outcome, Died accounts for the largest share at 55.6%. Annual submission volume spans 2,010 to 2,025 reports across the 15 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 0 tracked guinea pig breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.